Attch_0021_ACWS_Additional_Price_Matrix_2016_09_30.xlsx

Cover

Amendment 0008:

- All Tabs: Revised and labeled CELL Color Key (Top Right)

- All Tabs: For CLIN 0001 Program Management added new SLIN 0001AA Program Mgt, SLIN 0001AB Earned Value Management and Total CLIN Line

- All Tabs: Revised title for CLIN totals to add "CLIN #", Grayed out all Cells "N/A"

- Tab Price Evaluation Summary: Grayed out previously "White" Cells that are pulled from other sheets (Build & Support)

- Tab Support: "Closed" Year 1 and Year 2 (No Support Task Orders); "Opened" - for Price Entry, CLIN 0005 Training; "Closed" and marked "N/A", no Price, CLIN 0007 Org Change Management

NOTE: Offeror shall refer to Tab: CLIN Task Order Chart, RFP Attachments 0001 SOO, (Figure 4); Offeror's Proposed Attachment 0015 Staff and Salary Mix Schedule and Proposed IMS for reconciling the inputs.

Price Evaluation Summary Offeror/Cage:

$ - 0 $ - 0 $ - 0 $ - 0

EVALUATED SLIN 0001AA PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

$ - 0 $ - 0 $ - 0 $ - 0

EVALUATED SLIN 0001AB PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

EVALUATED CLIN 0001 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 $ - 0 $ - 0

EVALUATED CLIN 0002 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 $ - 0 N/A

EVALUATED 0003 CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 N/A N/A

EVALUATED 0004 CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 N/A N/A

EVALUATED 0005 CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 $ - 0 N/A

EVALUATED 0006 CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 N/A N/A

EVALUATED 0007 CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 $ - 0 N/A

EVALUATED 0008 CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 $ - 0 N/A

EVALUATED 0009 CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

N/A N/A N/A $ - 0

EVALUATED 0010 CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ - 0 $ - 0 N/A

EVALUATED CLIN 0011 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Risk Reduction Build Support Transition Out

$ - 0 $ 4,200,000 N/A $ - 0

EVALUATED CLIN 0012 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 4,200,000

$ - 0 $ 10,000,000 N/A $ - 0

EVALUATED CLIN 0013 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 10,000,000

Risk Reduction Build Support Transition Out

NSP NSP NSP NSP

EVALUATED CLIN 0014 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NSP

Risk Reduction Build Support Transition Out

NSP NSP NSP NSP

EVALUATED CLIN 0015 NOT SEPARATELY PRICED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NSP

TOTAL EVALUATED PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 14,200,000

ATTACHMENT 0020

Individual Builds Offeror/Cage:

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL SLIN 0001 AA PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL SLIN 0001 AB PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

TOTAL BUILD CLIN 0001 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0002 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0003 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD 0004 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0005 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0006 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0007 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0008 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0009 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

N/A N/A N/A N/A N/A N/A

TOTAL BUILD CLIN 0011 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N/A

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0011 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0012 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 4,200,000

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

TOTAL BUILD CLIN 0013 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 10,000,000

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

NSP NSP NSP NSP NSP NSP

TOTAL BUILD CLIN 0014 PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NSP

Build #1 Build #2 Build #3 Build #4 Build #5 Build #6

NSP NSP NSP NSP NSP NSP

BUILD CLIN 0015 NOT SEPARATELY PRICED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NSP

Support Offeror/Cage:

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED SLIN 0001AA PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED SLIN 0001AB PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

EVALUATED CLIN 0001 TOTAL PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

N/A N/A N/A N/A N/A N/A N/A N/A N/A

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N/A

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

N/A N/A N/A N/A N/A N/A N/A N/A N/A

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N/A

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

N/A N/A N/A N/A N/A N/A N/A N/A N/A

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N/A

$ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0 $ - 0

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ - 0

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N/A

N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N/A

NSP NSP NSP NSP NSP NSP NSP NSP NSP NSP

EVALUATED CLIN PRICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NSP

NSP NSP NSP NSP NSP NSP NSP NSP NSP NSP

SUPPORT CLIN 0015 NOT SEPARATELY PRICED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NSP

CLIN Task Order Chart

Attachment 0001 Statement of Objectives, Figure 4

Microsoft_Word_Document1.docx Unclassified

ARMY CONTRACT WRITING SYSTEM

(ACWS)

Attachment 0021

ACWS_Additional _Price_Matrix

Version 1.1

30 Sep 2016

Solicitation Number: W52P1J-16-R-0058

Prepared By:

Product Manager

Army Contract Writing System (ACWS)

PAST PERFORMANCE QUESTIONNAIRE (PPQ)

RFP W52P1J-16-R-0058 Army Contract Writing System (ACWS)

OFFEROR NAME and CAGE:

SECTION I – GENERAL GUIDANCE

Introduction: Under solicitation W52P1J-16-R-0058 ACWS, the Army Contracting Command at Rock Island, IL (ACC-RI) is obtaining past performance information. The completed PPQ serves as a source of information to evaluate the Offerors recent and relevant performance of the submitted project/contract reference (listed in Section IIB below) as it relates to the solicitation.

Instructions:

1. Offerors shall –

· Complete Section IIA and IIB, then email entire PPQ to the intended PPQ Respondent.

· Instruct the PPQ Respondent to complete Section III.

· Respondents to the PPQ shall –

· Complete Section III entirely, to include comments (if any)

· Send the completed PPQ to the ACC-RI Contracting Officer Jonathan Anderson, jonathan.j.anderson16.civ@mail and Contract Specialist John Hemmen, john.p.hemmen.civ@mail.

· Recommended format for email Subject: “Completed PPQ for W52P1J-16-R-0058, [Offeror Name or Abbreviation]-[referenced contract number]”.

· Recommended PPQ electronic document filename: “[Offeror Name or Abbreviation]_PPQ_ACWS_[contract reference number].doc” or “.docx” or “.pdf”.

· Send the completed PPQ to the Contract Specialist identified above. DO NOT send a copy of the completed PPQ to the Offeror.

In addition to the submitted PPQ email response, Respondents may receive follow-up phone calls for clarification purposes from an ACC-RI Official. This is a critical acquisition and as such comments are appreciated for all ratings as applicable.

RATING

DESCRIPTION

Excellent

The Offeror's past performance far exceeds the customer's expectations and provided significant, unusual worthwhile features or benefits.

Good

The Offeror’s past performance exceeds the customer's expectations and provided significant, unusual worthwhile features or benefits.

Satisfactory

The Offeror's past performance met the customer's expectations and contract requirements.

Marginal

The Offeror's past performance could have been improved. The Offeror required major agency resources to ensure achievement of contract requirements.

Unsatisfactory

The Offeror's past performance did not meet customer expectations and/or contract requirements.

SECTION II (To be completed by the Offeror A. 1 - 6 and B. 1 - 9)

A. RESPONDENT IDENTIFICATION

1.

Name & Job Title:

2.

Organization:

3.

Address:

4.

Phone No:

5.

Email:

6.

Date:

B. CONTRACT IDENTIFICATION

1.

CAGE and Company (if other than a prime contract holder and first tier subcontractor)

2.

Contract Name:

3.

Contract Identification Number:

4.

Order Number(s) (if applicable):

5.

Date of Contract Award and total contract value:

6.

Average Annual value of the Contract (provide the number of years used to calculate the average):

(if any) Estimated Products Value:

(if any) Estimated Services Value:

7.

Period of Actual Contract Performance

8.

CONUS and/or OCONUS locations:

9.

Describe the products and/work the work effort performed on this referenced contract or as a subcontractor. Word count is limited to no more than 500 words maximum:

THE FOLLOWING IS TO BE COMPLETED BY THE RESPONDENT POC.

SECTION III. CONTRACT PERFORMANCE

1.

Name and Respondent’s Job Title (e.g. COR, Contracting Officer, etc.)

2.

Indicate your satisfaction with Offeror’s performance in providing software products and related deliverables that were compliant with stated requirements, met expectations established in their original proposal, and were configured / maintained up to standards of good workmanship.

Exceptional ____

Very Good ____ Satisfactory ____

Marginal ____

Unsatisfactory )___

3.

Indicate your satisfaction with Offeror’s performance in providing systems integration services and related deliverables that were compliant with service level agreements, appropriate to the work effort required to meet specifications, and effective at designing, developing, testing, operating, and maintaining systems in accordance with predetermined performance standards and objectives.

Exceptional ____

Very Good ____

Satisfactory ____

Unsatisfactory ___

4.

Indicate your satisfaction with the Offeror’s performance managing critical project variables such as schedule, reporting, human resources, risk identification and mitigation, and change management.

Exceptional ____

Very Good ____

Satisfactory ____

5.

Indicate your satisfaction with the Offeror’s performance obtaining, installing, configuring, and delivering software solutions in a timely manner.

Exceptional ____

Very Good ____

Satisfactory ____

6.

Taking into consideration the original performance timelines and scheduling influences outside of the Offeror’s control; indicate your satisfaction with the Offeror’s performance in establishing, maintaining, and executing tasks based on a resource allocated schedule.

Exceptional ____

Very Good ____

Satisfactory ____

Marginal ____

Unsatisfactory __

7.

Indicate your satisfaction with the Offeror’s effectiveness at consistently accounting, reporting, and billing for allowable costs on mixed type contracts (contracts with Firm Fixed Price and Cost Reimbursable line items).

Exceptional ____

Very Good ____

Satisfactory ____

8.

Indicate your satisfaction with the Offeror’s effectiveness of developing, implementing, and improving financial forecasting and cost control measures for Cost-Reimbursable cost elements.

Exceptional ____

Very Good ____

Satisfactory ____

9.

Indicate your satisfaction with the Offeror’s methodology for creating and maintain a professional relationship with business partners, customers, and stakeholders that aligns to the customer’s interests and while fostering a mutually beneficial relationship.

Exceptional ____

Very Good ____

Satisfactory ____

10. Please provide any other relevant performance information that you think would be important for the Government to consider as part of this assessment:

11. Are you aware of other relevant past efforts by this company? If yes, please provide the name and telephone number of a point of contact:

Name

Email Address

Telephone Number

THANK YOU FOR YOUR RESPONSES

image1.png image2.png image1.emf image2.png